 Artist: Live: mp3 download Genre(s): Rock: Pop-Rock ROck: Alternative Live's discography:  Distance To Here Year: 2005 Tracks: 13  Awake: The Best Of Year: 2004 Tracks: 19  Heaven Year: 2003 Tracks: 4  Birds Of Pray Year: 2003 Tracks: 13  V Year: 2001 Tracks: 15  Overcome Year: 2001 Tracks: 3  Secret Samadhi Year: 1997 Tracks: 12  Throwing Copper (Limited Edition) Year: 1994 Tracks: 14  Mental Jewelry Year: 1991 Tracks: 12 Live pink wine to chart success on the persuasiveness of its anthemic music and sublime, overtly ghostly songwriting, deuce hallmarks which earned the group haunt comparisons to U2. Live first base formed in the early '80s in their hometown of York, Pennsylvania, when future members Chad Taylor (guitar), Patrick Dahlheimer (sea bass) and Chad Gracey (drums) began playing unitedly under the list "First Aid" patch attendance centre school day. After losing an area talent competition, they decided to engage singer Ed Kowalczyk, and as a quartet the group played under a series of name career before settling on Public Affection. Afterward earning a fanatic local following, in 1989 Public Affection released a cassette, The Death of a Dictionary, on their own Action Front tag. After graduating to CBGB and early celebrated New York clubs, they earned a demonstration manage with Giant Records which proven abortive; the completed demo earned them a apportion with Radioactive, however, and ahead drafting their new mention out of a hat, Live recruited Talking Head Jerry Harrison to bring forth their 1991 debut, Mental Jewelry. A ingathering of songs based on the writings of Indian philosopher Jiddu Krishnamurti, the record made Live one of the key players in the post-Nirvana alternative medicine scene thanks to singles like "Procedure Spirit (The Tyranny of Tradition)" and "Painfulness Lies on the Riverside." Terzetto years later, Live returned with the muscular Throwing Copper, which lingered a number of months on the charts ahead pushing the chemical group into the rock 'n' roll mainstream; after a series of popular singles like "Selling the Drama" and "I Alone," the album's tedious build climaxed with the sepulchral "Lightning Crashes," which propelled the record album to the top of the charts and paved the elbow room for the hits "White, Discussion" and "All Over You." Private Samadhi, the third Live LP, followed in early 1997, simply failed to agree either the commercial or critical succeeder of late efforts. The dance band resurfaced deuce years later with The Distance to Here. Through 2003, the dance band continually refined their challenging, spiritual effectual; both 2001's V and 2003's Birds of Pray cracked the Billboard Top 30. |
Wednesday 10 September 2008
Mp3 music: Live
Sunday 31 August 2008
Mp3 music: Avulsed
 Artist: Avulsed: mp3 download Genre(s): Rock Metal: Death,Black Avulsed's discography:  Gorespattered Suicide Year: 2005 Tracks: 12  Yearning For The Grotesque Year: 2003 Tracks: 10  Stabwound Orgasm Year: 1999 Tracks: 14 Based out of Madrid, Spain, the quintuple of Avulsed has maintained their lyrical rigour and death alloy chops since their formation in 1992. Consisting of Cabra (guitar), Juancar (guitar), Furni (drums), Dave Rotten (vocals), and Tana (bass), the get-go uncut Distinction in Putrescence was followed by a fistful of demos and the 1992 7" EP Carnivoracity. After their 1998 techno remix record album Cybergore, the Colombian-based Quirofano Productions compiled all of Avulsed's demos and unreleased recordings for the compilation Seven Years of Decay. Their securities and Exchange Commission album, Stabwound Orgasm, followed that like year. |
Fear of Vaccine Fuels Measles Outbreak
Thursday 21 August 2008
Britney Nominated For Top VMA!
Could this be the beginning of the comeback for Britney Spears?
Last year's MTV Video Music Awards turned her into a riant stock after that disastrous live performance.
But this time around Brit's actually organism recognized for something honest for once!
It has just now been announced that her video for Piece of Me has been nominative for the big award -- video of the year.
She's up against the Jonas Brothers for Burnin Up,' Chris Brown for Forever, the Pussycat Dolls for When I Grow Up and newcomers The Ting Tings for Shut Up and Let Me Go, according to NYTimes.com.
But if she picks up the top award at the ceremony in L.A. in September, it could kick initiate a gravid 2009 for the asterisk, who says in the latest issue of OK! that she's fighting to get her career back on track.
The Toxic singer's already been nominated by fans for best bug out video and best female video for Piece of Me.
The land site also says that Spear could sustain a chance to redeem herself after last year's car-crash appearance on stagecoach, because her people
Monday 11 August 2008
Colo. collective goes with Flobots
Amazing things happen when radio stations support their local bands.
Just ask Denver�s Flobots.
Two months after their hometown station KTCL-FM added the sung dynasty �Handlebars� to its revolution in January, the live rap-rock outfit signed a major-label record deal with Universal Republic.
Of course Flobots - which plays a sold-out Middle East gig Sunday with People Under the Stairs - didn�t truly blow up overnight. Like so many recently discovered bands, the politically progressive collective has been grinding for years.
�We�ve been around since 2005,� said Flobots MC Jonny 5. �We were doing shows in Denver every two or three months to build up the hype. Before any
record book labels came at us we were already making money on our CDs and shows and we had a whole movement of people behind us. So it was a good business decision on (Universal�s) part.�
Not that Flobots was now prepared to push past Colorado. Jonny 5 says it took time for the grouping - which includes trumpet and genus Viola players inaddition to a rhythm section and deuce MCs - to engineer the hard-edged orchestral sound that characterizes the band�s debut, �Fight With Tools.�
�It took a while for all of us to get to know each other musically and office as a collective,� he aforesaid, �and that came with us getting to know each other as people.�
The Flobots too were busy making connections outside the group. Determined to be more of a philanthropic alliance than an ordinary band, members established a nonprofit organization to learn music to abused and traumatized children in Greater Denver.
�We were finding ways to integrate music into our day jobs and to mix values into our medicine,� Jonny 5 aforementioned. �We were setting everything up so that a lot of us could work for the not-for-profit and in music at the same time. And then �Handlebars� hit and we had to reshuffle our plans.�
Even on spell, band members stay tortuous through FightWithTools.org, an on-line resource they created to help activists and organizers network.
�There�s a different type of warfare happening too the war in Iraq,� Jonny 5 said. �It�s a warfare for our minds and allegiances. It�s about where we put our resources as people. We pauperization to be as loud and as vocal and intense as those wHO are nerve-wracking to enter people into the former war.�
Skeptics mightiness question why a band intent on raging against the car would foretoken to a major label such as Universal Republic, home to such embarrassinglyvapid hip-hop acts of the Apostles as Baby Boy Da Prince and the Shop Boyz. But Jonny 5 has an answer, besides the index of Universal Republic to give the Flobots worldwide market exposure.
�People in the record diligence are people too,� Jonny 5 said, �and people right now ar upset about the state of war in Iraq and the Bush presidency. A set of people at the label are excited to have their day jobs give them an opportunity to participate and speak out. It may hail to a point where our interests aren�t in line, simply we�ll deal with that if it comes.�
More info
Wednesday 6 August 2008
Single-Pill Combinations Diovan HCT And Exforge Approved In US As First-Line Treatments For High Blood Pressure
�The US Food and Drug
Administration (FDA) has approved two single-pill combination medications,
Diovan HCT(R) (diovan and hydroDIURIL) and Exforge(R)
(amlodipine and valsartan), as initial or 'first-line' therapies in
patients likely to need multiple drugs to achieve their blood LC142% HCT, Tekturna, or Exforge have
generally been mild and brief. The most usual side effects with Diovan and
Diovan HCT ar headache and dizziness. A side effect experienced by more
patients taking Tekturna than patients taking a sugar pill was diarrhoea.
Side effects that occurred more oftentimes with Exforge than placebo are
gibbousness of the hands, ankles, or feet; nasal congestion or huffy throat;
straits or chest cold; and dizziness.
Disclaimer
The foregoing discharge contains forward-looking statements that can be
identified by terminology such as "whitethorn", "could", "potential", "suggests",
"will", "risk", "confidence", or standardized expressions, or by give tongue to or
implied discussions regarding potential future revenues from Diovan HCT and
Exforge. Such innovative statements reflect the current views of the
Company regarding succeeding events, and involve known and unknown risks,
uncertainties and early factors that may effort actual results with Diovan
HCT and Exforge to be materially different from any future results,
functioning or achievements expressed or implied by such statements. There
can be no guarantee that Diovan HCT and Exforge will achieve any particular
levels of revenue in the future. In finicky, management's expectations
regarding Diovan HCT and Exforge could be affected by, among other things,
the company's ability to obtain or maintain patent or early proprietary
noetic property tribute; competition in general; governing,
industry and general public pricing pressures; unexpected regulative
actions or delays or government regularisation generally; unexpected clinical
trial results, including unexpected new clinical information and unexpected
additional analysis of existing clinical information; and other risks and factors
referred to in Novartis AG's current Form 20-F on file with the US
Securities and Exchange Commission. Should nonpareil or more of these risks or
uncertainties materialize, or should underlying assumptions prove
incorrect, actual results may diverge materially from those awaited,
believed, estimated or expected. Novartis is providing the information in
this weightlift release as of this date and does non undertake any obligation to
update whatever forward-looking statements contained in this press release as a
consequence of new information, future events or otherwise.
About Novartis
Novartis Pharmaceuticals Corporation researches, develops, manufactures
and markets leading modern prescription drugs used to treat a number of
diseases and conditions, including those in the cardiovascular, metabolic,
cancer, organ transplantation, central uneasy system, dermatological, GI
and respiratory areas. The company's mission is to ameliorate people's lives
by pioneering novel health care solutions.
Located in East Hanover, New Jersey, Novartis Pharmaceuticals
Corporation is an affiliate of Novartis AG (NYSE: NVS), which provides
healthcare solutions that speak the evolving needs of patients and
societies. Focused solely on growth areas in health care, Novartis offers a
diversified portfolio to best meet these of necessity: innovative medicines,
cost-saving generic pharmaceuticals, interference vaccines and diagnostic
tools, and consumer health products. Novartis is the only when company with
leading positions in these areas. In 2007, the Group's chronic
operations (excluding divestments in 2007) achieved net gross sales of USD 38.1
billion and net income of USD 6.5 billion. Approximately USD 6.4 one thousand million
was invested in R&D activities passim the Group. Headquartered in
Basel, Switzerland, Novartis Group companies employ approximately 98,000
full-time associates and operate in over cxl countries around the universe.
For more information, please visit hTTP://www.novartis.com.
Novartis Pharmaceuticals Corporation
http://www.novartis.com
View drug info on Diovan; Tekturna.
More info
Administration (FDA) has approved two single-pill combination medications,
Diovan HCT(R) (diovan and hydroDIURIL) and Exforge(R)
(amlodipine and valsartan), as initial or 'first-line' therapies in
patients likely to need multiple drugs to achieve their blood LC142% HCT, Tekturna, or Exforge have
generally been mild and brief. The most usual side effects with Diovan and
Diovan HCT ar headache and dizziness. A side effect experienced by more
patients taking Tekturna than patients taking a sugar pill was diarrhoea.
Side effects that occurred more oftentimes with Exforge than placebo are
gibbousness of the hands, ankles, or feet; nasal congestion or huffy throat;
straits or chest cold; and dizziness.
Disclaimer
The foregoing discharge contains forward-looking statements that can be
identified by terminology such as "whitethorn", "could", "potential", "suggests",
"will", "risk", "confidence", or standardized expressions, or by give tongue to or
implied discussions regarding potential future revenues from Diovan HCT and
Exforge. Such innovative statements reflect the current views of the
Company regarding succeeding events, and involve known and unknown risks,
uncertainties and early factors that may effort actual results with Diovan
HCT and Exforge to be materially different from any future results,
functioning or achievements expressed or implied by such statements. There
can be no guarantee that Diovan HCT and Exforge will achieve any particular
levels of revenue in the future. In finicky, management's expectations
regarding Diovan HCT and Exforge could be affected by, among other things,
the company's ability to obtain or maintain patent or early proprietary
noetic property tribute; competition in general; governing,
industry and general public pricing pressures; unexpected regulative
actions or delays or government regularisation generally; unexpected clinical
trial results, including unexpected new clinical information and unexpected
additional analysis of existing clinical information; and other risks and factors
referred to in Novartis AG's current Form 20-F on file with the US
Securities and Exchange Commission. Should nonpareil or more of these risks or
uncertainties materialize, or should underlying assumptions prove
incorrect, actual results may diverge materially from those awaited,
believed, estimated or expected. Novartis is providing the information in
this weightlift release as of this date and does non undertake any obligation to
update whatever forward-looking statements contained in this press release as a
consequence of new information, future events or otherwise.
About Novartis
Novartis Pharmaceuticals Corporation researches, develops, manufactures
and markets leading modern prescription drugs used to treat a number of
diseases and conditions, including those in the cardiovascular, metabolic,
cancer, organ transplantation, central uneasy system, dermatological, GI
and respiratory areas. The company's mission is to ameliorate people's lives
by pioneering novel health care solutions.
Located in East Hanover, New Jersey, Novartis Pharmaceuticals
Corporation is an affiliate of Novartis AG (NYSE: NVS), which provides
healthcare solutions that speak the evolving needs of patients and
societies. Focused solely on growth areas in health care, Novartis offers a
diversified portfolio to best meet these of necessity: innovative medicines,
cost-saving generic pharmaceuticals, interference vaccines and diagnostic
tools, and consumer health products. Novartis is the only when company with
leading positions in these areas. In 2007, the Group's chronic
operations (excluding divestments in 2007) achieved net gross sales of USD 38.1
billion and net income of USD 6.5 billion. Approximately USD 6.4 one thousand million
was invested in R&D activities passim the Group. Headquartered in
Basel, Switzerland, Novartis Group companies employ approximately 98,000
full-time associates and operate in over cxl countries around the universe.
For more information, please visit hTTP://www.novartis.com.
Novartis Pharmaceuticals Corporation
http://www.novartis.com
View drug info on Diovan; Tekturna.
More info
Thursday 19 June 2008
Frank Sinatra - Sinatra Continues Royalties Fight
FRANK SINATRA's daughter NANCY is continuing her late father's fight for musicians' rights - the singer is to urge the U.S. government to change the current law on radio royalties.
Ten years before his death in 1998, Frank Sinatra pushed for the introduction of legislation to give performance royalties to artists whose songs air on radio.
And nearly two decades on, his daughter Nancy is continuing his efforts.
On Wednesday (11Jun08), Nancy is to join stars including rocker Dave Navarro and hip-hop group the Sugarhill Gang, to speak at a congressional hearing in Washington D.C. on behalf of the MusicFirst coalition.
The hearing will discuss supporting new legislation which will give new rights to performers.
See Also
Friday 13 June 2008
Featured Photos: Metallica at the KROQ Weenie Roast - May 2008
Metallica [ tickets ] has taken to the road several times over the course of their studio work on their latest album. The latest excuse to do so was widely-reported to be the highlight of Los Angeles area alt-rock station KROQ's annual summer concert gathering, the venerable Weenie Roast.LiveDaily's Tim Mosenfelder caught some of the action with his trusty Nikons.
Subscribe to:
Posts (Atom)